Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.

Hepatology · 2023 · PMC10026969 · PMID 35993369

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

SR staining showed a trend toward decreased collagen‐1 deposition after pacritinib treatment (Figure 4 D, middle panel).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.